Thomson Reuters , will move its U.S. stock listing to Nasdaq from the New York Stock Exchange later this month, the content ...

and innovation-focused index tracking 100 of the largest non-financial companies listed on the Nasdaq Stock Market®. Now, 40 years later, the Nasdaq-100® is the world’s preeminent large-cap ...

The three stocks detailed on this list have had their days in the sun but haven’t exhibited anywhere near the consistency of NVIDIA and Broadcom. Below, I’ll examine three giant names in the ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

This tool has been used by Wall Street analysts on certain stocks in recent rating changes. Today, as the first quarter earnings results become available, Wells Fargo analysts have decided to share ...

In early trading on Monday, shares of Idexx Laboratories, topped the list of the day's best performing components of the Nasdaq 100 index ... community featuring stock message boards, ratings ...

Insider buying was solid in January, including dividend-paying names like Lakeland Industries (NASDAQ: LAKE), York Water (NASDAQ: YORW), and RLI Corp (NYSE: RLI). These stocks are not only the most ...

Other Value-added Data – Includes market status information including Stock Directory ... consolidated volume on a real-time basis for Nasdaq-listed securities, as well as, NYSE-, NYSE MKT ...

Nasdaq Last Sale feeds provide unrivaled access to trading data globally, allowing millions of people around the world to access Nasdaq validated data in real time. NLS provides real-time intraday ...

Genprex , Inc., a pharmaceutical company based in Austin, Texas, has received notifications from The Nasdaq Stock Market indicating non-compliance with certain listing requirements. Currently trading ...

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where ...

Strategy's share sales from its at-the-market offering were just below 3% of the total cumulative trading volume.